Examples of using Scleroderma in English and their translations into Vietnamese
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Scleroderma: causes, types, photo, symptoms and treatment.
According to some reports, L-carnitine is effective for focal scleroderma.
About the bones it appears the so-called” scleroderma- the skin hardens like the bark of a t….
If the patient has all of these symptoms,then there is a suspicion of systemic scleroderma.
Organic scleroderma of various forms and localization- 3000-45000 IU intramuscularly 1 time in 3 days.
IT is positive in 95-100% of MCTD;may also be positive up to 30~50% of those with SLE and Scleroderma.
Heart, lungs or kidneys. Scleroderma can affect the function of the heart, lungs or kidneys to varying degrees.
Diagnosis can be difficult because some of the early symptoms are common in the general population andaren't always associated with scleroderma.
Scleroderma is a chronic, progressive disease of the connective tissue, which is characterized by its hardening, compaction and scarring.
Expertise: Diagnosis and treatment of rheumatic diseases such as scleroderma, pulmonary fibrosis, dermatomyositis, and Behcet's disease.
With systemic scleroderma, skin changes may occur suddenly and progressively worsen during the first one to two years of the disease.
Conditions that affect the glands that make saliva-like Sjögren's syndrome and scleroderma- also can cause dry mouth and bad breath.
The two main varieties of localized scleroderma, which affects only the skin, are distinguished by very distinctive signs and symptoms.
Systemic diseases of the connective tissue,including systemic lupus erythematosus, scleroderma(increased risk of agranulocytosis or neutropenia);
We then expanded our studies to scleroderma and specifically looked at the role of EZH2 in fibroblasts and endothelial cells in this disease.”.
Systemic Diseases- These are diseases that affect many organs and tissues or affect the whole body,including lupus, scleroderma, amyloidosis.
As there are currently no effective treatment options for scleroderma, Sawalha notes that this type of research is important for future studies and trials.
Systemic diseases: These are diseases that affect a number of organs and tissues, or affect the body as a whole,they include lupus, scleroderma, amyloidosis.
The signs and symptoms of systemic scleroderma usually begin with episodes of Raynaud's phenomenon, which can occur weeks to years before fibrosis.
Raynaud's phenomenon can also occur in people who have Sjogren's syndrome-an autoimmune disorder that may accompany scleroderma, lupus or rheumatoid arthritis.
With localized scleroderma, the first signs of disease may be the presence of Raynaud's phenomenon and may develop several years before you notice any other symptoms.
Disease of the adhesive tissue and joints, collagenase or mixed collagenases, rheumatoid arthritis, primary chronic polyarthritis,Lupus erythematosus, scleroderma, Raynaud-syndrome.
Hormones: because women develop scleroderma more often than men, researchers suspect that hormones may play a role, but the role of female hormones has not been proven.
In a new study, published in Proceedings of the National Academy of Sciences,Sawalha and his team examined scleroderma at the molecular level to better understand the fibrosis process.
CREST syndrome is associated with detectable antibodies against centromeres(a component of the cell nucleus), and usually spares the kidneys(a featuremore common in the related condition systemic scleroderma).
In 1809,Christiaan Persoon provided the first modern scientific description, as Scleroderma callostoma, and suggested that the species might be distinctive enough to warrant the creation of a new genus.
Researchers have long suspected that occupational exposure to silica dust may account for the higher rates of autoimmune rheumatic diseases, including rheumatoid arthritis,lupus and scleroderma(a skin condition) found in individuals working in these jobs.
Chinese food therapyhas great effect on treating cancer, scleroderma, muscular atrophy, rheumatism, motor neuron disease, fibromyalgia, diabetes, nephropathy, and other kinds of chronic diseases and severe cases.
The earliest symptoms of scleroderma usually involve thickening of the skin and a condition known as Reynaud's phenomenon, which constricts the arteries and turns the fingers blue when they're exposed to cold.
In 2004,CAT and Genzyme revealed that Phase I/II trials of metelimumab for scleroderma showed this antibody to be safe and well tolerated across all dose levels, although no conclusions regarding efficacy of the compound could be made.[6].